Intuitive Surgical Surges on Upgraded 2026 Outlook

Intuitive Surgical Inc. has enhanced its financial projections for 2026, now forecasting between 13.5% and 15.5% growth in procedures utilizing its da Vinci surgical robotic system. This upward revision, exceeding previous guidance and analyst predictions, was announced alongside first-quarter earnings that surpassed market expectations.

The company's chief executive highlighted robust performance in US general surgery and expanding international use outside of urology as key drivers for the improved outlook. However, he also acknowledged potential risks, including economic uncertainties in Europe and heightened competition within China.

First-quarter adjusted earnings per share reached $2.50, exceeding the $2.10 consensus estimate. Worldwide da Vinci procedures saw a significant 16% increase, surpassing analyst forecasts of 14.8%. Performance was particularly strong in the United States and Europe, though challenges were noted in China and Japan.

This positive financial update comes as Intuitive Surgical navigates an increasingly competitive landscape. Medtronic Plc's Hugo robotic system and CMR Surgical's Versius Plus platform have recently entered the US market, intensifying rivalry in the surgical robotics sector. The company also faced regulatory scrutiny and a data breach in March, though these events did not materially impact first-quarter financial results.